Antibody-free PRISM-SRM for multiplexed protein quantification: Is this the new competition for immunoassays in bioanalysis?

Bioanalysis

Volumn 5, Issue 3, 2013, Pages 267-269

  Shi, Tujin ^a   Qian, Wei Jun ^a  

^a PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

Author keywords

high resolution separations; immunoassay; intelligent selection; multiplexed assays; proteomics; sensitivity; SRM; targeted quantification

Indexed keywords

PEPTIDE; PLASMA PROTEIN; PROSTATE SPECIFIC ANTIGEN; PROTEIN; PROTEIN ANTIBODY;

ANTIBODY AFFINITY; ANTIBODY LABELING; ANTIGEN ANTIBODY REACTION; BIOTECHNOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PRESSURE HIGH REOLUTION SEPARATION WITH INTELLIGENT SELECTION AND MULTIPLEXING SRM ASSAY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PROGNOSIS; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN ISOLATION; PROTEIN TARGETING; PROTEOMICS; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; SYSTEMS BIOLOGY;

HUMANS; IMMUNOASSAY; MASS SPECTROMETRY; PROTEIN BINDING; PROTEINS; PROTEOMICS;

EID: 84873573303     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.12.336     Document Type: Review

References (19)

1. Shi T, Su D, Liu T et al. Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics. Proteomics 12(8), 1074-1092 (2012
2. Whiteaker JR, Lin C, Kennedy J et al. A targeted proteomics-based pipeline for verification of biomarkers in plasma. Nat. Biotechnol. 29(7), 625-634 (2011
3. Makawita S, Diamandis EP. The bottleneck in the cancer biomarker pipeline and protein quantification through mass spectrometry-based approaches: Current strategies for candidate verification. Clin. Chem. 56(2), 212-222 (2010
4. Keshishian H, Addona T, Burgess M, Kuhn E, Carr SA. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol. Cell. Proteomics 6(12), 2212-2229 (2007
5. Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation:the long and uncertain path to clinical utility. Nat. Biotechnol. 24(8), 971-983 (2006
6. Lange V, Malmstrom JA, Didion J et al. Targeted quantitative analysis of Streptococcus pyogenes virulence factors by multiple reaction monitoring. Mol. Cell. Proteomics 7(8), 1489-1500 (2008
7. Picotti P, Aebersold R. Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat. Methods 9(6), 555-566 (2012
8. Shi T, Fillmore TL, Sun X et al. Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum. Proc. Natl Acad. Sci. USA 109(38), 15395-15400 (2012
9. Addona TA, Abbatiello SE, Schilling B et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat. Biotechnol. 27(7), 633-641 (2009
10. Kuhn E, Whiteaker JR, Mani DR et al. Inter-laboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma. Mol. Cell. Proteomics 11(6), M111.013854 (2012
11. Picotti P, Bodenmiller B, Mueller LN, Domon B, Aebersold R. Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics. Cell 138(4), 795-806 (2009
12. Hoofnagle AN, Becker JO, Oda MN, Cavigiolio G, Mayer P, Vaisar T. Multiple-reaction monitoring-mass spectrometric assays can accurately measure the relative protein abundance in complex mixtures. Clin. Chem. 58(4), 777-781 (2012
13. Anderson L, Hunter CL. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell. Proteomics 5(4), 573-588 (2006
14. Whiteaker JR, Zhao L, Anderson L, Paulovich AG. An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers. Mol. Cell. Proteomics 9(1), 184-196 (2010
15. Whiteaker JR, Zhao L, Lin C, Yan P, Wang P, Paulovich AG. Sequential multiplexed analyte quantification using peptide immunoaffinity enrichment coupled to mass spectrometry. Mol. Cell. Proteomics 11(6), M111.015347 (2012
16. Rafalko A, Dai SJ, Hancock WS, Karger BL, Hincapie M. Development of a chip/chip/ SRM platform using digital chip isoelectric focusing and LC-chip mass spectrometry for enrichment and quantitation of low abundance protein biomarkers in human plasma. J. Proteome Res. 11(2), 808-817 (2012
17. Wang Q, Chaerkady R, Wu J et al. Mutant proteins as cancer-specific biomarkers. Proc. Natl Acad. Sci. USA 108(6), 2444-2449 (2011
18. Wolf-Yadlin A, Hautaniemi S, Lauffenburger DA, White FM. Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks. Proc. Natl Acad. Sci. USA 104(14), 5860-5865 (2007
19. Hoofnagle AN, Wener MH. The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry. J. Immunol. Methods 347(1-2), 3-11 (2009